102650-30-6
102650-30-6
Chemical Structure
Bz-DTPA
- CAS No.: 102650-30-6
- Formula:C22H28N4O10S
- Molecular Weight:540.54
InChIKey: VAOYPHGXHKUTHC-KRWDZBQOSA-N
SMILES: OC(CN(CC(O)=O)[C@H](CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O)CC1=CC=C(C=C1)N=C=S)=O
Biological Activity: Bz‑DTPA is a bifunctional chelator that can conjugate indium radionuclides to targeting proteins for tumor-targeted tracing. Bz‑DTPA is mainly used in studies related to radioactive targeting molecules[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Bz-DTPA | 96.18% | Bz‑DTPA is a bifunctional chelator that can conjugate indium radionuclides to targeting proteins for tumor-targeted tracing. Bz‑DTPA is mainly used in studies related to radioactive targeting molecules. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Tolmachev V, et al. Comparative biodistribution of potential anti-glioblastoma conjugates [111In]DTPA-hEGF and [111In]Bz-DTPA-hEGF in normal mice. Cancer biotherapy & radiopharmaceuticals. 2004 Aug;19(4):491-501.
- [2]. Tolmachev V, et al. The influence of Bz‑DOTA and CHX‑A''‑DTPA on the biodistribution of ABD‑fused anti‑HER2 Affibody molecules: implications for 114mIn‑mediated targeting therapy. Eur J Nucl Med Mol Imaging, 2009, 36:1460‑1468.
